PamGene International B.V.

Name: PamGene International B.V.
Address: Wolvenhoek 10, 'S-Hertogenbosch, 5211HH, NL
Telephone: +31 (0)73 6158080

Startpagina
Nederland
's-Hertogenbosch
PamGene International B.V.

PamGene has developed a novel 3D microarray platform for the measurement of protein activities, with applications in Biomarkers for Oncology and Medicine.

PamGene has developed a novel 3D microarray platform for the measurement of protein activities, currently focusing on kinases (tyrosine & serine/threonine) and nuclear receptors. PamGene has developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. Products: (https://www.pamgene.com/en/Products.htm):
PamStation-12 ®, Pa

mchip arrays ® and Reagent kits, are available world-wide through distributors, agents and directly from PamGene. Services: (https://www.pamgene.com/en/Services.htm)
PamGene also works in partnership with the drug development industry to improve on current R&D practices especially for lead optimization, translational/ preclinical research and biomarker discovery. PamGene and users of its technology platform are supporting clinical trials in the oncology area. Applications in other areas (CNS, Immunology, CVD, respiratory) are being explored. PamGene has a strong science foundation and the number of publications applying our continues to rise. PamGene's Customer Service team supports your research with dedication. The PamAcademy offers advanced training, from workflows to data analysis, interpretation and storage. PamGene's PamCloud space allows User-interaction to further knowledge exploration. Please visit our web site for further information (https://www.pamgene.com/) and get in touch with us! (https://www.pamgene.com/en/landing.htm)

19/12/2019

Season's Greetings from PamGene! https://www.pamgene.com/en/news/156/season's-greetings.htm

16/11/2015

Kinase activity decreases with Alzheimer's disease progression (https://www.pamgene.com/en/news/123/kinase-activity-decreases-with-alzheimer's-disease-progression.htm)

14/10/2015

You can download our latest Brochures from our website: https://www.pamgene.com/en/Brochures.htm

14/10/2015

Insights into nuclear receptor functions in 4 publications this year!
Interesting publications in 2015, from research groups that have used PamGene's Nuclear receptor profiling technology, highlight novel applications that provide insights into nuclear receptor function.
https://www.pamgene.com/en/news/122/insights-into-nuclear-receptor-functions-in-4-publications-this-year.htm

14/10/2015

A step closer to realizing personalized lung cancer treatment. A Dutch–German public-private consortium of PamGene, GenXpro and the University Medical Center Groningen has been awarded a research grant from the EU Eurostars-2 program for the Triple T project of € 1.55 million: Rationalized Tailored Targeted Therapy for Cancer.
https://www.pamgene.com/en/news/120/a-step-closer-to-realizing-personalized-lung-cancer-treatment.htm

14/10/2015

Recently PamGene participated again in the philanthropic initiative "Swim to fight Cancer". All together we can realize that cancer is no longer a deadly disease! https://www.pamgene.com/en/news/119/pamgene-team-in-the-swim-to-fight-cancer!.htm

14/10/2015

Adres

Wolvenhoek 10
'S-Hertogenbosch
5211HH

Telefoon

+31 (0)73 6158080

Website

https://www.pamgene.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer PamGene International B.V. nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.